June 08, 2021
Rising demand for minimally invasive surgical methodologies, surging geriatric populace, soaring obesity incidences along with technical advancements are the major factors propelling the growth of worldwide spinal non-fusion devices industry.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557577/
It is to be noted that degenerative disc disease often leads to chronic back or neck pain, and disc herniation. Non-fusion spinal technologies as well as disc diagnostic devices are thus helpful for patients suffering from gradual disc damage, which is enhancing the adoption of these devices.
On the contrary, stringent governmental dictum coupled with precarious reimbursing directives might prohibit the growth of the market during the analysis timeframe.
The intelligence report offers manifold record of the growth catalysts, prospects, and limitations that will shape the market scenario during 2018-2026. It further entails inputs from Subject Matter Experts and Key Opinion Leaders to understand the latest trends as well as to enable investors to make informed decisions.
Speaking of product gamut, global spinal non-fusion devices industry is classified into dynamic stabilization devices, artificial discs replacement, and others. Based on end user terrain, the market is bifurcated into orthopedic centers, hospitals, and others.
Moving on, the country-level fragmentation of worldwide spinal non-fusion devices industry consists of the United States, the United Kingdom, Germany, France, Italy, Spain, and Japan.
The competitive landscape of global spinal non-fusion devices market is defined by companies such as B. Braun Melsungen AG, Medtronic plc, Johnson & Johnson (J&J), Centinel Spine LLC, Stryker Corporation, Globus Medical Inc., NuVasive Inc., RTI Surgical, and Zimmer Biomet among others.